Equities

Galderma Group AG

Galderma Group AG

Actions
  • Price (CHF)79.50
  • Today's Change0.08 / 0.10%
  • Shares traded349.17k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 16:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments368234287
Total Receivables, Net766791732
Total Inventory420442347
Prepaid expenses563537
Other current assets, total7.104.50115
Total current assets1,6161,5071,517
Property, plant & equipment, net529401342
Goodwill, net5,1295,1295,141
Intangibles, net4,9235,1005,282
Long term investments108.807.30
Note receivable - long term------
Other long term assets293516
Total assets12,47112,41512,572
LIABILITIES
Accounts payable557602502
Accrued expenses526535506
Notes payable/short-term debt000
Current portion long-term debt/capital leases63413427
Other current liabilities, total424411421
Total current liabilities1,5711,9611,857
Total long term debt4,8465,2455,261
Total debt4,9095,6585,689
Deferred income tax431432519
Minority interest------
Other liabilities, total255308387
Total liabilities7,1027,9468,024
SHAREHOLDERS EQUITY
Common stock6,2595,2485,248
Additional paid-in capital------
Retained earnings (accumulated deficit)(901)(844)(745)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total116446
Total equity5,3694,4694,548
Total liabilities & shareholders' equity12,47112,41512,572
Total common shares outstanding238238238
Treasury shares - common primary issue0.330.330.33
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.